BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17714760)

  • 1. Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation.
    Guo H; Cajaiba MM; Borys D; Gutierrez MC; Yee H; Drut RM; Drut R; Askin F; Reyes-Múgica M; Greco MA
    Hum Pathol; 2007 Dec; 38(12):1772-8. PubMed ID: 17714760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
    Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
    Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G
    Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations.
    Rossi G; Gasser B; Sartori G; Migaldi M; Costantini M; Mengoli MC; Piccioli S; Cavazza A; Rivasi F
    Histopathology; 2012 Jun; 60(7):1133-43. PubMed ID: 22348416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser microdissection allows detection of abnormal gene expression in cystic adenomatoid malformation of the lung.
    Jancelewicz T; Nobuhara K; Hawgood S
    J Pediatr Surg; 2008 Jun; 43(6):1044-51. PubMed ID: 18558180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.
    Ishida M; Igarashi T; Teramoto K; Hanaoka J; Iwai M; Yoshida K; Kagotani A; Tezuka N; Okabe H
    Int J Clin Exp Pathol; 2013; 6(11):2597-602. PubMed ID: 24228126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype.
    Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G
    J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
    Sheikh Ali MA; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Demircan K; Fujii M; Yamanaka N; Shimizu K; Grenman R; Nagai N
    Cancer Sci; 2008 Aug; 99(8):1589-94. PubMed ID: 18754871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital cystic adenomatoid malformation of the lung: insights into the pathogenesis utilizing quantitative analysis of vascular marker CD34 (QBEND-10) and cell proliferation marker MIB-1.
    Cangiarella J; Greco MA; Askin F; Perlman E; Goswami S; Jagirdar J
    Mod Pathol; 1995 Dec; 8(9):913-8. PubMed ID: 8751331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.
    Tawbi H; Thomas D; Lucas DR; Biermann JS; Schuetze SM; Hart AL; Chugh R; Baker LH
    Oncologist; 2008 Apr; 13(4):459-66. PubMed ID: 18448562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic and p53 profiles in congenital cystic adenomatoid malformation: insights into its relationship with pleuropulmonary blastoma.
    Vargas SO; Korpershoek E; Kozakewich HP; de Krijger RR; Fletcher JA; Perez-Atayde AR
    Pediatr Dev Pathol; 2006; 9(3):190-5. PubMed ID: 16944975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital cystic adenomatoid malformation with associated mucinous bronchioloalveolar carcinoma in a neonate.
    Li J; Chen GS; Zhang X; Moore L; Cheng H
    Fetal Pediatr Pathol; 2014 Feb; 33(1):29-34. PubMed ID: 24093545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA; Zhang S; Katzenstein AL
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung.
    West D; Nicholson AG; Colquhoun I; Pollock J
    Ann Thorac Surg; 2007 Feb; 83(2):687-9. PubMed ID: 17258019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralobar pulmonary sequestration associated with a congenital pulmonary airway malformation type II.
    Couluris M; Schnapf BM; Gilbert-Barness E
    Fetal Pediatr Pathol; 2007; 26(5-6):207-12. PubMed ID: 18363152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients.
    Reinmuth N; Jauch A; Xu EC; Muley T; Granzow M; Hoffmann H; Dienemann H; Herpel E; Schnabel PA; Herth FJ; Gottschling S; Lahm H; Steins M; Thomas M; Meister M
    Lung Cancer; 2008 Nov; 62(2):193-201. PubMed ID: 18450321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous adenocarcinoma of the lung in association with congenital pulmonary airway malformation.
    Summers RJ; Shehata BM; Bleacher JC; Stockwell C; Rapkin L
    J Pediatr Surg; 2010 Nov; 45(11):2256-9. PubMed ID: 21034957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.